GSA Capital Partners LLP Lowers Stake in Phreesia, Inc. (NYSE:PHR)

by · The Cerbat Gem

GSA Capital Partners LLP reduced its holdings in shares of Phreesia, Inc. (NYSE:PHR – Free Report) by 56.4% during the 1st quarter, according to its most recent 13F filing with the SEC. The fund owned 35,219 shares of the company’s stock after selling 45,531 shares during the period. GSA Capital Partners LLP owned approximately 0.06% of Phreesia worth $900,000 as of its most recent filing with the SEC.

Other hedge funds and other institutional investors also recently bought and sold shares of the company. Principal Financial Group Inc. purchased a new position in Phreesia during the 1st quarter worth $1,623,000. Deutsche Bank AG grew its position in Phreesia by 95.9% during the 4th quarter. Deutsche Bank AG now owns 57,297 shares of the company’s stock worth $1,442,000 after purchasing an additional 28,047 shares during the last quarter. Bessemer Group Inc. grew its position in Phreesia by 23.2% during the 1st quarter. Bessemer Group Inc. now owns 47,758 shares of the company’s stock worth $1,222,000 after purchasing an additional 8,978 shares during the last quarter. SG Americas Securities LLC purchased a new position in Phreesia during the 1st quarter worth $462,000. Finally, Raymond James Financial Inc. purchased a new position in Phreesia during the 4th quarter worth $379,000. 92.10% of the stock is owned by hedge funds and other institutional investors.

Phreesia Stock Down 0.2%

PHR stock opened at $26.97 on Friday. The company has a market cap of $1.60 billion, a P/E ratio of -36.44 and a beta of 0.72. Phreesia, Inc. has a 52 week low of $17.07 and a 52 week high of $30.53. The company’s 50-day moving average price is $26.78 and its 200 day moving average price is $26.41. The company has a current ratio of 1.95, a quick ratio of 1.95 and a debt-to-equity ratio of 0.02.

Phreesia (NYSE:PHR – Get Free Report) last released its quarterly earnings data on Wednesday, May 28th. The company reported ($0.07) EPS for the quarter, topping analysts’ consensus estimates of ($0.13) by $0.06. The firm had revenue of $115.94 million for the quarter, compared to the consensus estimate of $115.00 million. Phreesia had a negative net margin of 9.83% and a negative return on equity of 16.23%. The firm’s revenue was up 14.5% on a year-over-year basis. During the same quarter in the previous year, the firm earned ($0.05) earnings per share. On average, research analysts expect that Phreesia, Inc. will post -1.1 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

PHR has been the topic of several analyst reports. Citigroup reaffirmed a “buy” rating on shares of Phreesia in a report on Wednesday, May 28th. Wall Street Zen raised shares of Phreesia from a “hold” rating to a “buy” rating in a report on Sunday, June 1st. Truist Financial lifted their target price on shares of Phreesia from $34.00 to $35.00 and gave the company a “buy” rating in a report on Thursday, May 29th. KeyCorp lifted their target price on shares of Phreesia from $28.00 to $35.00 and gave the company an “overweight” rating in a report on Monday, July 14th. Finally, DA Davidson raised shares of Phreesia to a “strong-buy” rating in a report on Tuesday, July 22nd. Eleven research analysts have rated the stock with a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat, Phreesia has a consensus rating of “Buy” and an average price target of $32.27.

Read Our Latest Stock Report on Phreesia

Insider Activity at Phreesia

In other Phreesia news, Director Michael Weintraub sold 7,431 shares of Phreesia stock in a transaction dated Monday, June 9th. The shares were sold at an average price of $27.51, for a total transaction of $204,426.81. Following the completion of the transaction, the director owned 143,039 shares in the company, valued at approximately $3,935,002.89. The trade was a 4.94% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, COO Evan Roberts sold 1,892 shares of Phreesia stock in a transaction dated Thursday, July 17th. The stock was sold at an average price of $26.89, for a total transaction of $50,875.88. Following the transaction, the chief operating officer owned 772,915 shares of the company’s stock, valued at approximately $20,783,684.35. The trade was a 0.24% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 53,804 shares of company stock valued at $1,510,733 in the last quarter. 5.50% of the stock is owned by corporate insiders.

Phreesia Company Profile

(Free Report)

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.

Read More

Want to see what other hedge funds are holding PHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Phreesia, Inc. (NYSE:PHR – Free Report).